Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.
Jonathan ThouveninOmar AlhalabiMaria Isabel CarloLucia Carril-AjuriaLaure HirschNieves Martinez-ChanzaSylvie NégrierLuca CampedelDylan MartiniDelphine BorchielliniJad ChahoudMassimo LodiPhilippe BarthélémyElshad HasanovAndrew W HahnThierry GilSrinivas R ViswanathanZiad BakounyPavlos MsaouelMehmet Asim BilenToni K ChoueiriLaurence AlbigesNizar M TannirGabriel G MaloufPublished in: The oncologist (2022)
This real-world study provides evidence of the activity of cabozantinib in TRCC, with more durable responses than those observed historically with other VEGFR-TKIs or ICIs.